Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A.I.D.S. is a true public health problem in Central Africa since its "appearance" in 1983. Several authors have described its clinical manifestations, as well as the absence of groups at risk and a sex ratio near to 1. The present study, carried out in Pointe-Noire hospital (Popular Republic of Congo) tries to select in connexion with sex and age, one or several clinical symptoms which should indicate the necessity of requesting a HIV serology test. Four groups have been isolated: a) patients with very important loss of weight and chronic or intermittent diarrhea, b) fever with loss of weight and pulmonary X-Ray anomalies, c) polyadenopathies, d) associated opportunistic infections and Kaposi sarcoma. In Africa, A.I.D.S. strikes all age groups and both sex. There is one group at risk: transfused patients, particularly the sickle-cell anemia homozygotes.
 ...
PMID:[Clinical aspects of AIDS and related syndromes in Pointe-Noire (Peoples' Republic of Congo). Apropos of 73 cases detected in 6 months]. 364 96

We report a case of Kaposi's sarcoma of the bone marrow presenting as a myelophthisic anemia with bone marrow necrosis. The patient did not fit into any of the current clinical patterns described for Kaposi's sarcoma. This case illustrates the need for including Kaposi's sarcoma in the differential diagnosis of myelophthisic anemia.
 ...
PMID:Kaposi's sarcoma of the bone marrow. 377 27

We studied two cases of a recently recognized systemic lymphoproliferative disease with morphological features of Castleman's disease: multicentric giant lymph node hyperplasia. Both patients developed Kaposi's sarcoma and had laboratory evidence of immune abnormalities, including reversed T4 to T8 ratios. One patient's disease had a subacute course with fevers of unknown origin, mucocutaneous candidiasis, and progressive thrombocytopenia, while the other patient's disease had a fulminant course with anemia, thrombocytopenia, and splenic lymphoma. Both patients were elderly, and both died of complications of multicentric giant lymph node hyperplasia.
 ...
PMID:Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma. 384 Mar 53

Since December 1980, over 3000 cases of acquired immunodeficiency syndrome (AIDS) have been reported. The charts of 102 patients admitted to the New York University Medical Center with a diagnosis of AIDS were reviewed with particular emphasis on presenting signs, symptoms, and laboratory values. Symptoms tended to be nonspecific and most often resembled those of an upper respiratory infection. Over 71% of the patients presented with at least two of the following four signs: diffuse adenopathy, oral and facial lesions consistent with Kaposi's sarcoma, white oral lesions, and anergy. Laboratory findings included leukopenia, increased erythrocyte sedimentation rate, thrombocytopenia, and anemia. The in-hospital mortality rate was 26%. The current status of our knowledge concerning AIDS is reviewed and discussed. The frequency and types of presenting signs and symptoms in the head and neck are reported to alert the otolaryngologic community to this entity.
 ...
PMID:Head and neck presentations of acquired immunodeficiency syndrome. 393 90

Single-agent intravenous vinblastine, 4 to 8 mg/week, was used to treat 38 patients with Kaposi's sarcoma related to the acquired immunodeficiency syndrome. The dose was titrated in relation to the total leukocyte count. Ten patients had an objective response, and 19 had stable disease during therapy. Apart from expected modest neutropenia, toxicity was minimal. A lower response rate was seen in patients with anemia, an elevated erythrocyte sedimentation rate, or any lymphoma-like B symptom. Opportunistic infections were common regardless of type of response but were commoner in patients who did not respond. Vinblastine used in low doses weekly is effective in treating Kaposi's sarcoma related to the acquired immunodeficiency syndrome and has minimal associated toxicities.
 ...
PMID:Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. 402 82

Observations of 12 patients with AIDS at this institution from March 1981 to April 1984 are reported. Ten patients were homosexuals and two were bisexual. The majority had travelled abroad (USA, Haiti) and reported multiple anonymous sexual contracts. Eleven patients reported symptoms and signs, of 2-12 months' duration, frequently seen in pre-AIDS: fatigue (10), weight loss (10), diarrhea (7), night sweats (5), fever (4), and generalized lymphadenopathy (1). Laboratory studies showed anemia (10), lymphopenia (9), leukopenia (7), decreased T-helper/T-suppressor ratio (10) and cutaneous anergy to multiple skin-test antigens (9). P. carinii pneumonia was diagnosed in three patients, P. carinii pneumonia and Kaposi's sarcoma in one patient and Kaposi's sarcoma in six patients. Another patient had a chronic mucocutaneous infection with herpes simplex and another an intestinal cryptosporidiosis and Kaposi's sarcoma. Alpha-A-interferon was used to treat patients with Kaposi's sarcoma and three patients with limited disease showed a favorable response. Six patients with advanced disease died.
 ...
PMID:[Acquired immune deficiency syndrome in the region of Zurich. Report on 12 cases]. 649 67

Since December 1980, over 2,000 cases of acquired immunodeficiency syndrome (AIDS) have been reported. The charts of 72 patients admitted to the New York University Medical Center with a diagnosis of AIDS were reviewed with particular emphasis on presenting signs, symptoms and laboratory values. Symptoms tended to be non-specific and most often resembled an upper respiratory infection. Over 95% of the patients presented with either diffuse adenopathy, oral or facial lesions consistent with Kaposi's sarcoma, white oral lesions, or anergy. Laboratory findings included leukopenia, increased erythrocyte sedimentation rate, thrombocytopenia and anemia. The in-hospital mortality rate was 26%. The current status of our knowledge concerning AIDS is reviewed and discussed. The frequency and types of presenting signs and symptoms in the head and neck are reported in order to alert the otolaryngologic community to this entity.
 ...
PMID:Head and neck presentations of acquired immunodeficiency syndrome. 671 22

A 34-year-old black South African male was treated for lymphangioma-like clinical Kaposi's sarcoma. The disease followed a rapidly fatal course and was characterized by unexplained recurrent pleural effusions and severe refractory anaemia due to the presence of dilated vascular channels in the bone marrow. Definitive diagnosis was only made at autopsy. Lymphangiomatous changes in the skin without spindle cell formation caused diagnostic difficulties.
 ...
PMID:Rapidly fatal lymphangioma-like Kaposi's sarcoma. 742 35

Preclinical and clinical studies with an azidothymidine (AZT)/interferon-alpha (IFN-alpha) combination resulted in a marked and synergistic antiretroviral activity. The administration of the two drugs in HIV-seropositive patients affected with Kaposi's sarcoma, however, induced neutropenia, thrombocytopenia, and, in some cases, anemia. A possible means to improve the therapeutic index of AZT and/or IFN-alpha in AIDS patients could be the addition of hematopoietic growth factors. In vitro activity of cytokines on the hematotoxicity of the AZT-IFN-alpha association has not yet been studied. We have performed an in vitro study to evaluate the toxicity of AZT, IFN-alpha, or both on peripheral blood hematopoietic progenitors (CFU-GM and BFU-E) and to assess the activity of interleukin 1 (IL-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), or both in modifying AZT-IFN-alpha hematotoxicity. Results indicate that AZT, IFN-alpha, and combinations of the two have a dose-dependent inhibitory effect on the in vitro growth of peripheral blood hematopoietic progenitors. Combinations of AZT and IFN-alpha inhibited CFU-GM and BFU-E proliferation in an additive manner. Neither IL-1 nor GM-CSF alone was able to induce a significant reduction of AZT-induced damage. Only the addition to the cultures of both cytokines partially curbed the antiproliferative activity of AZT at low dosages.
 ...
PMID:Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF. 749 65

The author is a medical missionary in southern Africa. He describes the human devastation wrought by HIV/AIDS in the region. The adult wards remain filled with young, wasted males and females with persistent coughs and other manifestations of tuberculosis (TB), generalized lymphadenopathy, Kaposi's sarcoma, pyogenic infection, and neural and ocular manifestations of HIV infection. The main reason for admission to the wards is to exclude or identify treatable infections, especially pulmonary TB. The lack of physical and other resources, however, result in the early discharge of terminal and untreatable cases. Deaths which do occur in the hospital are most commonly caused by untreatable TB or profuse diarrhea combined with chronic wasting and anemia. The children's ward is largely populated by babies and toddlers with a combination of pneumonia and failure to thrive, while outpatient clinics simply providing a preview of future inpatients. The author points out that this heavy toll of AIDS-related morbidity and mortality does not exist in a vacuum, but in the context of many other long-standing diseases. Many AIDS patients die in a state of denial. Finally, there are numerous personal, social, and psychological ramifications associated with each case of AIDS.
 ...
PMID:Out of control. 761 5


<< Previous 1 2 3 4 5 6 7 8 9 Next >>